About

Servaas Michielssens, PhD, CFA

Head of Healthcare, Thematic Global Equity

Download a photo

Servaas Michielssens is the Head of Healthcare at Candriam since 2024. Previously, he was Senior Fund Manager and Biotechnology Analyst with Candriam from 2016 to 2022.   

His other financial experience includes two years in private equity (from 2022), and two years as a risk analyst at Axa. Servaas began his career as a Doctoral Researcher at Katholieke Universiteit Leuven in 2007 and joined Max Planck Institute in Germany as a researcher in 2012.  

Servaas holds a Master in Science and a Ph.D. in Chemistry (Katholieke Universiteit Leuven). He has been a CFA Charterholder since 2018. 

Discover the latest articles by Servaas Michielssens

Q&A, Healthcare, Linden Thomson, Servaas Michielssens

Biotech investing: is there a doctor in the house?

Servaas Michielssens and Linden Thomson answer investors’ questions about a sector where depth of specialist knowledge is a prerequisite to consistent stock selection success.
Oncology, Q&A, Servaas Michielssens, Linden Thomson, Equities

Investing in oncology: forewarned is forearmed

Servaas Michielssens and Linden Thomson explain to investors the approach they used to create and develop an investment strategy in the oncology sector.
Loading...

Find it fast

Get information faster with a single click

Get insights straight to your inbox